Better Pharmacotherapy in Heart Failure with Reduced Ejection Fraction May Partly Explain the Obesity Paradox

Overview

Journal Eur J Heart Fail

Publisher Wiley

Specialty Cardiology & Vascular Diseases

Date 2023 Mar 28

PMID 36974755

Authors

Salvatore Carbone

Andrew Elagizi

Carl J Lavie

Affiliations

Soon will be listed here.

Citing Articles

Dietary Interventions in Heart Failure With Preserved Ejection Fraction: A Scoping Review.

Billingsley H, Carbone S, Driggin E, Kitzman D, Hummel S JACC Adv. 2025; 4(1):101465.

PMID: 39801812 PMC: 11719370. DOI: 10.1016/j.jacadv.2024.101465.

Reinhardt M, Schupp T, Behnes M, Lau F, Schmitt A, Abel N J Clin Med. 2024; 13(17).

PMID: 39274363 PMC: 11396372. DOI: 10.3390/jcm13175151.

References

Hales C, Carroll M, Fryar C, Ogden C . Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. NCHS Data Brief. 2020; (360):1-8. View

Lavie C, Cahalin L, Chase P, Myers J, Bensimhon D, Peberdy M . Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc. 2013; 88(3):251-8. PMC: 7242812. DOI: 10.1016/j.mayocp.2012.11.020. View

Kim Y, Canada J, Kenyon J, Billingsley H, Arena R, Lavie C . Effects of Replacing Sedentary Time With Physical Activity on Mortality Among Patients With Heart Failure: National Health and Nutrition Examination Survey Follow-Up Study. Mayo Clin Proc. 2022; 97(10):1897-1903. PMC: 9547940. DOI: 10.1016/j.mayocp.2022.05.009. View

Elagizi A, Carbone S, Lavie C, Mehra M, Ventura H . Implications of obesity across the heart failure continuum. Prog Cardiovasc Dis. 2020; 63(5):561-569. PMC: 7521376. DOI: 10.1016/j.pcad.2020.09.005. View

Pandey A, Patel K, Lavie C . Obesity, Central Adiposity, and Fitness: Understanding the Obesity Paradox in the Context of Other Cardiometabolic Parameters. Mayo Clin Proc. 2018; 93(6):676-678. DOI: 10.1016/j.mayocp.2018.04.015. View

Carbone S, daSilva-deAbreu A, Lavie C . The sodium-glucose co-transporter 2 inhibitor dapagliflozin improves prognosis in systolic heart failure independent of the obesity paradox. Eur J Heart Fail. 2021; 23(10):1673-1676. PMC: 8628197. DOI: 10.1002/ejhf.2336. View

McAuley P, Keteyian S, Brawner C, Dardari Z, Al Rifai M, Ehrman J . Exercise Capacity and the Obesity Paradox in Heart Failure: The FIT (Henry Ford Exercise Testing) Project. Mayo Clin Proc. 2018; 93(6):701-708. DOI: 10.1016/j.mayocp.2018.01.026. View

Kim Y, Canada J, Kenyon J, Billingsley H, Arena R, Lavie C . Physical activity, sedentary behaviors and all-cause mortality in patients with heart failure: Findings from the NHANES 2007-2014. PLoS One. 2022; 17(7):e0271238. PMC: 9286289. DOI: 10.1371/journal.pone.0271238. View

Kokkinos P, Faselis C, Franklin B, Lavie C, Sidossis L, Moore H . Cardiorespiratory fitness, body mass index and heart failure incidence. Eur J Heart Fail. 2019; 21(4):436-444. DOI: 10.1002/ejhf.1433. View

10.

Cappelletto C, Stolfo D, Orsini N, Benson L, Rodolico D, Rosano G . Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry. Eur J Heart Fail. 2023; 25(5):698-710. DOI: 10.1002/ejhf.2795. View

11.

Lavie C, Laddu D, Arena R, Ortega F, Alpert M, Kushner R . Healthy Weight and Obesity Prevention: JACC Health Promotion Series. J Am Coll Cardiol. 2018; 72(13):1506-1531. DOI: 10.1016/j.jacc.2018.08.1037. View

12.

Carbone S, Arena R, Abbate A . Lack of Benefit for Liraglutide in Heart Failure. JAMA. 2016; 316(22):2429. DOI: 10.1001/jama.2016.15387. View

13.

Gaesser G, Angadi S . Obesity treatment: Weight loss versus increasing fitness and physical activity for reducing health risks. iScience. 2021; 24(10):102995. PMC: 8560549. DOI: 10.1016/j.isci.2021.102995. View

14.

Horwich T, Broderick S, Chen L, McCullough P, Strzelczyk T, Kitzman D . Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol. 2011; 108(12):1754-9. PMC: 3229667. DOI: 10.1016/j.amjcard.2011.07.051. View

15.

Billingsley H, Del Buono M, Canada J, Kim Y, Damonte J, Trankle C . Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction. Circ Heart Fail. 2022; 15(10):e009518. PMC: 9588574. DOI: 10.1161/CIRCHEARTFAILURE.122.009518. View

16.

Tutor A, Lavie C, Kachur S, Milani R, Ventura H . Updates on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2022; 78:2-10. DOI: 10.1016/j.pcad.2022.11.013. View

17.

Carbone S, daSilva-deAbreu A, Lavie C . Weighing in on weight loss in heart failure with reduced ejection fraction. Eur J Heart Fail. 2022; 25(1):128-130. PMC: 10284063. DOI: 10.1002/ejhf.2753. View